Liver cancer, new results for double immunotherapy
A new breakthrough in the treatment of advanced liver cancer, one of the most difficult to cure. This was highlighted...
A new breakthrough in the treatment of advanced liver cancer, one of the most difficult to cure. This was highlighted...
In our country, the decrease in cancer mortality is higher than the European average: -15% in men and -8% in...
Small progress grows. And so thanks to the combination of two immunotherapies plus two cycles of chemotherapy after four years...
If immunotherapy, implemented before surgery, works in patients with metastatic melanoma - the worst skin cancer - works, and works...
A change of mentality, for the patient and for the surgeon. This is what the results obtained from a study...
“I received chemotherapy and immunotherapy and my cancer disappeared. I haven't received any treatment since September 2020 and I'm still...
In recent decades, immuno-oncology has offered a fundamental contribution in improving patient survival, making chronic neoplasms previously very difficult to...
After the results obtained in recent years in metastatic disease, today patients with lung cancer receive new good news: those...
They had been anticipated in December and have now been officially presented at the annual meeting of the American Association...
There is a story that began less than 5 years ago in Milan, in a spin-off of the State University,...
Finding a way to make colorectal cancers susceptible to immunotherapy. This is the objective of a new study conducted by...
Just as the international conference 'Immunotherapy Bridge' is underway in Naples, conceived twelve years ago by Paul Asciertoan oncologist researcher...
The range of possible therapeutic opportunities is widening thanks to immunotherapy for gastrointestinal tumors, which is constantly increasing year after...
Immunotherapy is a powerful tool in the fight against cancer, especially in the case of tumors that are still difficult...
Treating early but high-risk melanoma with immunotherapy improves disease-free survival. Further confirmation comes from the CheckMate -76K study conducted in...